CD8A and non-small cell lung carcinoma: Furthermore, their study evidenced that the early surge in CX3CR1+ subset frequency among circulating CD8+ T cells was correlated to both responses by and prolonged survival of non-small cell lung cancer patients undergoing anti-PD-1 therapy.